Targeted Cancer Therapy Market By Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors, CAR-T Cell Therapy, Tyrosine Kinase Inhibitors, Angiogenesis Inhibitors), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Leukaemia, Lymphoma, Others), By Dosage Form (Oral, Injectable, Topical, and Others), By End-User (Hospitals, Cancer Research Centers, Specialty Clinics), Global Market Size, Segmental analysis, Regional Overview, Company Share Analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Oct 2024 | Report ID: MI1199 | 225 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Therapy Type

  • Monoclonal Antibodies
  • Immune Checkpoint Inhibitors
  • CAR-T Cell Therapy
  • Tyrosine Kinase Inhibitors
  • Angiogenesis Inhibitors

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Leukemia
  • Lymphoma
  • Others

By Dosage Form

  • Oral
  • Injectable
  • Topical
  • Others

End-User

  • Hospitals
  • Cancer Research Centers
  • Specialty Clinics

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies:

  • Roche
  • Novartis
  • Pfizer
  • Merck & Co.
  • Bristol-Myers Squibb
  • AstraZeneca
  • Amgen
  • Celgene
  • Gilead Sciences
  • Eli Lilly
  • Sanofi
  • Johnson & Johnson
  • Regeneron Pharmaceuticals
  • Takeda Pharmaceutical Company
  • Blueprint Medicines

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing